Dongpei Wu

483 total citations
19 papers, 384 citations indexed

About

Dongpei Wu is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Dongpei Wu has authored 19 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Genetics. Recurrent topics in Dongpei Wu's work include Receptor Mechanisms and Signaling (5 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Hypothalamic control of reproductive hormones (3 papers). Dongpei Wu is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Hypothalamic control of reproductive hormones (3 papers). Dongpei Wu collaborates with scholars based in United States and Canada. Dongpei Wu's co-authors include Joseph Pontillo, R. Scott Struthers, Chen Chen, Qiu Xie, Zhiqiang Guo, John Saunders, Yunfei Zhu, Fábio C. Tucci, Warren S. Wade and Martin W. Rowbottom and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Dongpei Wu

19 papers receiving 378 citations

Peers

Dongpei Wu
Timothy D. Gross United States
Rebecca L. Chan United States
Olaf Peters Germany
Angus R. Brown United Kingdom
Peter G. Klimko United States
Robert Dally United States
David G. Wettlaufer United States
Mathew M. Mulhern United States
Timothy D. Gross United States
Dongpei Wu
Citations per year, relative to Dongpei Wu Dongpei Wu (= 1×) peers Timothy D. Gross

Countries citing papers authored by Dongpei Wu

Since Specialization
Citations

This map shows the geographic impact of Dongpei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongpei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongpei Wu more than expected).

Fields of papers citing papers by Dongpei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongpei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongpei Wu. The network helps show where Dongpei Wu may publish in the future.

Co-authorship network of co-authors of Dongpei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongpei Wu. A scholar is included among the top collaborators of Dongpei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongpei Wu. Dongpei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
McCarver, Stefan J., Luke Elizabeth Hanna, Aaron A. Thompson, et al.. (2024). Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian Disruptions. ACS Medicinal Chemistry Letters. 15(4). 486–492. 1 indexed citations
3.
Savall, Brad M., Dongpei Wu, Devin M. Swanson, et al.. (2018). Discovery of Imidazo[1,2-a]pyrazines and Pyrazolo[1,5-c]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators. ACS Medicinal Chemistry Letters. 10(3). 267–272. 16 indexed citations
4.
Guo, Zhiqiang, Yongsheng Chen, Tao Hu, et al.. (2008). 5-Aryluracils as potent GnRH antagonists—Characterization of atropisomers. Bioorganic & Medicinal Chemistry Letters. 18(11). 3344–3349. 9 indexed citations
5.
Chen, Chen, Yongsheng Chen, Joseph Pontillo, et al.. (2008). Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 18(11). 3301–3305. 13 indexed citations
6.
Wu, Dongpei, Joseph Pontillo, Yinghong Gao, et al.. (2008). Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI). Bioorganic & Medicinal Chemistry Letters. 18(14). 4224–4227. 23 indexed citations
7.
Pontillo, Joseph, Dongpei Wu, Yinghong Gao, et al.. (2008). Synthesis and structure–activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics. Bioorganic & Medicinal Chemistry Letters. 18(23). 6151–6155. 7 indexed citations
9.
Kiankarimi, Mehrak, Martin W. Rowbottom, Dongpei Wu, et al.. (2006). Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2. Bioorganic & Medicinal Chemistry Letters. 16(18). 4922–4930. 9 indexed citations
10.
Rowbottom, Martin W., Brian Dyck, Mingzhu Zhang, et al.. (2006). Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1. Bioorganic & Medicinal Chemistry Letters. 16(17). 4450–4457. 6 indexed citations
11.
Guo, Zhiqiang, Yongsheng Chen, Charles Q. Huang, et al.. (2005). Uracils as potent antagonists of the human gonadotropin-releasing hormone receptor without atropisomers. Bioorganic & Medicinal Chemistry Letters. 15(10). 2519–2522. 20 indexed citations
12.
Guo, Zhiqiang, Dongpei Wu, Yunfei Zhu, et al.. (2005). Structure–activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(16). 3685–3690. 8 indexed citations
13.
Pontillo, Joseph, Zhiqiang Guo, Dongpei Wu, R. Scott Struthers, & Chen Chen. (2005). Synthesis of aryl-1,2,4-triazine-3,5-diones as antagonists of the gonadotropin-releasing hormone receptor. Bioorganic & Medicinal Chemistry Letters. 15(19). 4363–4366. 24 indexed citations
14.
Guo, Zhiqiang, Dongpei Wu, Yunfei Zhu, et al.. (2004). A convenient one-pot synthesis of asymmetric 1,3,5-triazine-2,4,6-triones and its application towards a novel class of gonadotropin-releasing hormone receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 693–698. 14 indexed citations
15.
Lollo, Charles P., et al.. (2003). Poly-L-Lysine-Based Gene Delivery Systems: Synthesis, Purification, and Application. Humana Press eBooks. 69. 1–13. 13 indexed citations
16.
Guo, Zhiqiang, Yongsheng Chen, Dongpei Wu, et al.. (2003). Synthesis and structure–Activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(20). 3617–3622. 20 indexed citations
17.
Zhu, Yunfei, Zhiqiang Guo, Timothy D. Gross, et al.. (2003). Design and Structure−Activity Relationships of 2-Alkyl-3-aminomethyl-6-(3-methoxyphenyl)-7-methyl-8-(2-fluorobenzyl)imidazolo[1,2-a]pyrimid-5-ones as Potent GnRH Receptor Antagonists. Journal of Medicinal Chemistry. 46(9). 1769–1772. 22 indexed citations
18.
Lollo, Charles P., Mariusz Banaszczyk, J. Fabrycki, et al.. (2000). Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo. Biochimica et Biophysica Acta (BBA) - General Subjects. 1523(1). 103–110. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026